Trials / Completed
CompletedNCT05971069
Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging
Real-time Identification of the Aberrant Left Hepatic Arterial Territory in the Liver Using Near-infrared Fluorescence Imaging: Prospective Study to Develop Decision Algorithm to Define the Preservation/Ligation of an Aberrant Left Hepatic Artery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
" Hepatic artery variants are occasionally seen, especially 20-30% of aberrant left hepatic artery. In radical gastrectomy, decision for aberrant left hepatic artery(ALHA) ligation should consider the oncologic safety and liver-related complication. Theoretically, the ALHA preservation is the most ideal in the aspect of liver function protection. However, it is technically difficult which consumes much time. Not only that, oncologic safety could be threatened as some soft tissues, including lymph nodes, could be remained while in preserving the ALHA. There has been no standardized method to evaluate the ALHA, and to decide whether preserve or ligate it. This prospective study has been designed to develop the decision algorithm to define the ALHA preservation/ligation, using near-infrared fluorescence imaging during surgery. "
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Group1 | Entire fluorescence defect on the Lt. lobe of liver → Preservation of the aberrant left hepatic artery |
| PROCEDURE | Group2 | Partial fluorecence defect on the Lt. lobe of liver → Ligation of the aberrant left hepatic artery |
| PROCEDURE | Group3 | No fluorescence defect on the Lt. lobe of liver → Ligation of the aberrant left hepatic artery |
Timeline
- Start date
- 2021-12-17
- Primary completion
- 2023-06-12
- Completion
- 2023-06-12
- First posted
- 2023-08-02
- Last updated
- 2023-08-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05971069. Inclusion in this directory is not an endorsement.